|Bid||4.44 x 312700|
|Ask||4.45 x 1100|
|Day's Range||4.4300 - 4.4699|
|52 Week Range||4.3900 - 7.5700|
|Beta (3Y Monthly)||1.05|
|PE Ratio (TTM)||9.19|
|Forward Dividend & Yield||0.16 (3.58%)|
|1y Target Est||N/A|
BOSTON, Dec. 3, 2018 /PRNewswire/ -- Santander Bank today announced that it has named David Harnisch Head of Commercial Banking. Harnisch joined Santander in 2017 as the Head of Underwriting, Portfolio Management and Commercial Strategy, and will now be responsible for leading and growing its commercial banking division.
November 16, 2018 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and an application submitted by Sanofi.
November 11, 2018 - New analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association (AHA) Scientific Sessions 2018. Praluent® (alirocumab) was associated with fewer deaths from any cause among patients who had previously experienced a heart attack or unstable angina (known as acute coronary syndrome, or ACS), and this was enhanced in patients who were followed for at least 3 years and those who had an LDL-C (low-density lipoprotein cholesterol) of 100 mg/dL or higher at baseline.
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial Praluent significantly reduced major adverse.
November 6, 2018 - The U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) in adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis, whose disease was inadequately controlled with topical therapies or for whom topical treatment was medically inadvisable. Currently, there are no FDA-approved systemic biologic medicines to treat adolescents with moderate-to-severe atopic dermatitis.
BOSTON, Nov. 5, 2018 /PRNewswire/ -- Santander Bank today announced the opening of its first branch in the Flushing neighborhood of Queens, located on 136-11 Roosevelt Avenue. To commemorate the event, Santander leaders will join community partners at a grand opening celebration and ribbon cutting later today to officially open the branch. Santander will present checks totaling $52,000 to three community organizations – Renaissance Economic Development Corporation (REDC), Chinese American Planning and Flushing Development Center.
New Platform to Help Businesses Simplify and Digitize Payment Processing BOSTON , Nov. 5, 2018 /PRNewswire/ -- Santander Bank today unveiled Santander® Enterprise Payment Link (EPL), a robust, host-to-host ...
November 1, 2018 - Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules (DNL747 and DNL758) target a critical signaling protein known as the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the TNF receptor pathway, which regulates inflammation and cell death in tissues throughout the body.
FDA approves asthma indication for Dupixent® (dupilumab) Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic.
Dengue fever is a debilitating disease typically leading to prolonged fever and severe joint pain. Dengue infection can progress unpredictably to a life-threatening form of the disease called dengue haemorrhagic fever that often requires hospitalized care. Today, there is no specific treatment available for dengue disease.
BOSTON, Oct. 17, 2018 /PRNewswire/ -- Santander Bank today announced that it has donated nearly $4 million to 135 non-profit organizations that support low- and moderate-income (LMI) individuals, families and communities primarily located in its Northeast footprint. One quarter of the funding – $1 million – is allocated to 13 community development financial institutions (CDFIs) through the Bank's CDFI Initiative, a special funding opportunity targeted to CDFIs working to stabilize neighborhoods, create and preserve affordable housing, deliver services to vulnerable populations, and provide assistance to diverse entrepreneurs and small businesses.
Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps Dupixent significantly reduced nasal.
BOSTON, Oct. 15, 2018 /PRNewswire/ -- Santander Bank today announced that it has expanded its Commercial Banking presence in the Southeast region and has named Fred Aldin as market director for Southeast commercial banking to lead the expansion. Santander also named Alex Terzi as head of Southeast foreign direct investment banking.
BOSTON, Oct. 4, 2018 /PRNewswire/ -- Santander Bank will celebrate the official re-opening of its flagship branch today following a redesign project that has transformed the space into a state-of-the-art destination in the heart of Boston's Financial District. Located at 75 State Street, also home to Santander's corporate headquarters, the new branch features a modern interior design and encourages engaging, consultative customer interactions in a comfortable setting while also providing tools to facilitate self-service. The Bank will hold a grand opening celebration and ribbon cutting this afternoon during National Customer Service Week where Santander executives will officially re-open the branch and present a check totaling $320,000 to City Year, a national education organization that helps students and schools succeed.
BOSTON, Oct. 2, 2018 /PRNewswire/ -- Santander Bank announced today the formation of its direct private investment practice and has named industry expert Michael Anthony to head the group. The practice connects Santander's Commercial Banking customers with potential family office partners who are able to provide non-traditional liquidity and alternative capital solutions through direct private investments. Michael, who brings over 20 years of experience in alternative investments and family office consulting, is based in Boston and reports to Robert Rubino, Santander Bank's co-president and head of Commercial Banking.
BOSTON, Sept. 27, 2018 /PRNewswire/ -- Santander Bank today announced that it is expanding its Commercial Banking presence in the Midwest region by naming Patrick Dunphy as its managing director and Midwest market head based in Chicago. Patrick brings more than 25 years of diverse experience in corporate and commercial banking to this new role.
BOSTON , Sept. 27, 2018 /PRNewswire/ -- Santander Bank announced today it has raised its prime rate from 5.00% to 5.25%, effective September 26, 2018 . Santander Bank , N.A . is one of the country's largest ...
BOSTON, Sept. 24, 2018 /PRNewswire/ -- Santander Bank today announced that Robert Cerminaro has joined the Bank as the regional executive of Commercial Banking for Connecticut. In this role, Cerminaro is responsible for growing the Bank's corporate and commercial business and delivering Santander's distinct value proposition and international expertise to clients and prospects throughout the state of Connecticut.
BOSTON, Aug. 21, 2018 /PRNewswire/ -- Santander Bank today announced the appointment of James Uehlinger as region president for the Bank's Metro New York/Northern New Jersey region. With more than 30 years of leadership experience in branch management, business banking and finance, Jim oversees all sales and services in over 160 retail branches, with more than 1,000 colleagues located across seven counties in northern and central New Jersey and the five Metro New York City boroughs. Jim comes to Santander Bank after more than 20 years with JPMorgan Chase at the leadership level where he held numerous positions of increasing responsibility across several divisions, many in the New York and New Jersey area.
Fourth major regulatory milestone in the last year marks most significant step yet towards resolving legacy issues BOSTON , Aug. 16, 2018 /PRNewswire/ -- Santander Holdings USA , lnc. ("SHUSA") ...
BOSTON, Aug. 16, 2018 /PRNewswire/ -- Santander Bank today announced that it is expanding its Commercial Banking presence in the Southwest region by naming Joanna Ridgway as its market head. As corporate market director for the Bank's Commercial Banking business in the Southwest, Joanna brings years of diverse experience in corporate and commercial banking to this new role.
BOSTON, July 24, 2018 /PRNewswire/ -- Santander Bank today announced that it has donated more than $3 million to 119 non-profit organizations that support low- and moderate-income individuals, families and communities primarily located in its Northeast footprint. "Small businesses are instrumental in contributing to the economic health and vibrancy of our communities, which is why we allocated a significant portion of our grant funding to support non-profit organizations that help them grow," said Gwen Robinson, Santander's Director of Corporate Social Responsibility.
BOSTON, July 17, 2018 /PRNewswire/ -- Santander Bank's Business Banking clients are being introduced to a new Bank Operating System this week in a move that will deliver a superior digital experience for customers that is as configurable and personalized as it is fast and easy-to-use. The Bank today announced it has integrated nCino's Bank Operating System with its Business Banking segment. A worldwide leader in cloud banking, nCino's cloud-based platform is accessible to customers from any device and will cut the time it takes the Bank to deliver loan decisions from start to finish by approximately 40 percent.
BOSTON , July 10, 2018 /PRNewswire/ -- Santander Bank today announced that Brian Schwinn has been appointed to head the Bank's asset based lending (ABL) and restructuring finance business in its Commercial ...